- Home
- SRRK vs CRNX Comparison
SRRK vs CRNX Comparison
Compare SRRK & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SRRK | CRNX |
|---|---|---|
| Founded | 2012 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 4.1B |
| IPO Year | 2018 | 2018 |
Fundamental Metrics
Financial Performance| Metric | SRRK | CRNX |
|---|---|---|
| Price | $47.62 | $45.28 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 9 |
| Target Price | $51.20 | ★ $75.78 |
| AVG Volume (30 Days) | 1.0M | ★ 1.1M |
| Earning Date | 02-26-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,535,000.00 |
| Revenue This Year | N/A | $499.13 |
| Revenue Next Year | $20,029.43 | $893.14 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 47.74 |
| 52 Week Low | $22.71 | $24.10 |
| 52 Week High | $49.82 | $57.99 |
Technical Indicators
Market Signals| Indicator | SRRK | CRNX |
|---|---|---|
| Relative Strength Index (RSI) | 53.53 | 38.75 |
| Support Level | $44.10 | $44.48 |
| Resistance Level | $49.82 | $50.57 |
| Average True Range (ATR) | 2.35 | 2.29 |
| MACD | -0.01 | -1.12 |
| Stochastic Oscillator | 45.47 | 16.47 |
Price Performance
Historical ComparisonAbout SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.